Skip to main content
Equibles

Frazier Life Sciences Management, L.P.

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 1892134 PALO ALTO, CA
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$45,860,853
-$5,253,523 QoQ
Shares Held
728,644
0.0% QoQ
Ownership
1.66%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#18
of 256 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Frazier Life Sciences Management, L.P. holds $4,497,017,185 across 37 Biotechnology names. TARS ranks #22 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MIRM
Mirum Pharmaceuticals, Inc.
 7,679,684 $899,060,605
2 NAMS
NewAmsterdam Pharma Co N.V.
 18,589,235 $623,725,004
3 ERAS
Erasca, Inc.
 24,975,188 $457,545,444
4 MBX
MBX Biosciences, Inc.
 6,652,013 $367,191,117
5 ARQT
Arcutis Biotherapeutics, Inc.
 9,874,511 $258,909,678
6 TRVI
Trevi Therapeutics, Inc.
 9,939,447 $185,370,686
7 KRYS
Krystal Biotech, Inc.
 481,307 $178,887,372
8 MAZE
Maze Therapeutics, Inc.
 5,032,915 $150,182,183

All Filings in TARS

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $45,860,853 728,644
2026-03-31 $51,114,376 728,644
2025-12-31 $59,661,370 728,644
2025-09-30 $69,386,129 1,167,527
2025-06-30 $56,613,818 1,397,527
2025-03-31 $71,790,961 1,397,527
2024-12-31 $87,901,369 1,587,527
2024-09-30 $52,213,763 1,587,527
2024-06-30 $43,148,983 1,587,527
2024-03-31 $64,976,606 1,787,527
2023-12-31 $36,197,421 1,787,527
2023-09-30 $31,764,354 1,787,527
2023-06-30 $32,300,612 1,787,527
2023-03-31 $22,469,214 1,787,527
2022-12-31 $26,205,145 1,787,527
2022-09-30 $30,602,462 1,787,527
2022-06-30 $26,097,894 1,787,527
2022-03-31 $23,836,580 1,417,157